Mark Lebwohl, MD
Ichan School of Medicine · Icahn School of Medicine at Mount Sinai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mark Lebwohl, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:24 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06336343 · Bimekizumab in Plaque PsoriasisIcahn School of Medicine at Mount Sinai · completed · Plaque Psoriasis · principal investigator
- Ph4NCT03403036 · Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A TherapiesIcahn School of Medicine at Mount Sinai · completed · Psoriasis · principal investigator
- Ph2NCT03123016 · Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of VitiligoIcahn School of Medicine at Mount Sinai · completed · Vitiligo · principal investigator
- Ph3NCT02899962 · LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis VulgarisLEO Pharma · completed · Psoriasis Vulgaris · principal investigator
- Ph2NCT02599129 · A Study of Secukinumab for the Treatment of Alopecia AreataIcahn School of Medicine at Mount Sinai · terminated · Alopecia Areata · principal investigator
- Ph1NCT02411851 · Treatment of Actinic Keratoses (AK) on the FaceIcahn School of Medicine at Mount Sinai · completed · Actinic Keratoses · principal investigator
- Ph2NCT02223039 · A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque PsoriasisAbGenomics B.V Taiwan Branch · completed · Moderate to Severe Chronic Plaque Psoriasis · principal investigator
- Ph4NCT02181790 · Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and SolesIcahn School of Medicine at Mount Sinai · terminated · Psoriasis, Skin or Nails · principal investigator
- N/ANCT02168244 · Reduction of Pain Caused by Biologic Drugs in PsoriasisIcahn School of Medicine at Mount Sinai · completed · Psoriasis, Pain · principal investigator
- N/ANCT01865032 · Evaluation of CL Detect™ Rapid Test to Detect Cutaneous LeishmaniasisU.S. Army Medical Research and Development Command · completed · Skin Diseases · principal investigator
- Ph2NCT01855880 · Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis PatientsAbGenomics B.V Taiwan Branch · completed · Moderate to Severe Chronic Plaque Psoriasis · principal investigator
- Ph1NCT01836939 · Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque PsoriasisMark Lebwohl · completed · Psoriasis · principal investigator
- Ph1NCT01836367 · Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and ScalpIcahn School of Medicine at Mount Sinai · completed · Actinic Keratosis · principal investigator
- Ph2NCT01525875 · Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)Mark Lebwohl · completed · Pseudoxanthoma Elasticum · principal investigator
- Ph3NCT01188928 · LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)LEO Pharma · completed · Psoriasis Vulgaris · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.